Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs PANACEA BIOTECH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CIPLA PANACEA BIOTECH CIPLA/
PANACEA BIOTECH
 
P/E (TTM) x 32.5 -61.7 - View Chart
P/BV x 5.2 0.9 585.3% View Chart
Dividend Yield % 0.6 0.0 -  

Financials

 CIPLA   PANACEA BIOTECH
EQUITY SHARE DATA
    CIPLA
Mar-23
PANACEA BIOTECH
Mar-23
CIPLA/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs1,185191 619.4%   
Low Rs852107 795.1%   
Sales per share (Unadj.) Rs281.975.1 375.4%  
Earnings per share (Unadj.) Rs35.1-5.5 -637.6%  
Cash flow per share (Unadj.) Rs49.70.9 5,654.8%  
Dividends per share (Unadj.) Rs8.500-  
Avg Dividend yield %0.80-  
Book value per share (Unadj.) Rs289.2137.7 210.0%  
Shares outstanding (eoy) m807.1561.25 1,317.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.62.0 181.8%   
Avg P/E ratio x29.0-27.1 -107.0%  
P/CF ratio (eoy) x20.5170.0 12.1%  
Price / Book Value ratio x3.51.1 325.0%  
Dividend payout %24.20-   
Avg Mkt Cap Rs m822,1649,142 8,993.6%   
No. of employees `000NANA-   
Total wages/salary Rs m38,3011,265 3,028.1%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m227,5314,599 4,946.9%  
Other income Rs m5,121517 991.3%   
Total revenues Rs m232,6535,116 4,547.5%   
Gross profit Rs m48,07947 102,251.6%  
Depreciation Rs m11,721391 2,996.0%   
Interest Rs m1,09544 2,468.8%   
Profit before tax Rs m40,384128 31,537.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m12,029466 2,584.0%   
Profit after tax Rs m28,355-337 -8,402.7%  
Gross profit margin %21.11.0 2,067.0%  
Effective tax rate %29.8363.5 8.2%   
Net profit margin %12.5-7.3 -169.9%  
BALANCE SHEET DATA
Current assets Rs m168,0515,623 2,988.5%   
Current liabilities Rs m50,3333,297 1,526.5%   
Net working cap to sales %51.750.6 102.3%  
Current ratio x3.31.7 195.8%  
Inventory Days Days7359 124.8%  
Debtors Days Days748 13.6%  
Net fixed assets Rs m117,3187,028 1,669.2%   
Share capital Rs m1,61461 2,635.6%   
"Free" reserves Rs m231,8458,375 2,768.4%   
Net worth Rs m233,4608,436 2,767.4%   
Long term debt Rs m0202 0.0%   
Total assets Rs m290,06712,712 2,281.9%  
Interest coverage x37.93.9 974.4%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.4 216.8%   
Return on assets %10.2-2.3 -440.4%  
Return on equity %12.1-4.0 -303.6%  
Return on capital %17.82.0 890.1%  
Exports to sales %22.643.3 52.3%   
Imports to sales %8.924.4 36.3%   
Exports (fob) Rs m51,5161,992 2,585.8%   
Imports (cif) Rs m20,2021,124 1,797.9%   
Fx inflow Rs m64,2821,992 3,226.6%   
Fx outflow Rs m20,2021,191 1,696.4%   
Net fx Rs m44,080801 5,500.6%   
CASH FLOW
From Operations Rs m32,377-4,225 -766.4%  
From Investments Rs m-23,8854,303 -555.0%  
From Financial Activity Rs m-9,583-184 5,215.8%  
Net Cashflow Rs m-968-105 921.9%  

Share Holding

Indian Promoters % 13.4 73.6 18.2%  
Foreign collaborators % 20.0 0.0 -  
Indian inst/Mut Fund % 50.0 1.0 5,262.1%  
FIIs % 25.7 0.3 9,896.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.5 26.4 251.9%  
Shareholders   425,731 47,091 904.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CIPLA With:   SUN PHARMA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    MANKIND PHARMA    


More on Cipla vs Panacea Biotech

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cipla vs Panacea Biotech Share Price Performance

Period Cipla Panacea Biotech S&P BSE HEALTHCARE
1-Day 2.92% -0.53% 1.44%
1-Month 2.22% -19.02% -0.50%
1-Year 69.64% 13.13% 62.23%
3-Year CAGR 22.92% -11.90% 18.26%
5-Year CAGR 23.47% -9.76% 19.85%

* Compound Annual Growth Rate

Here are more details on the Cipla share price and the Panacea Biotech share price.

Moving on to shareholding structures...

The promoters of Cipla hold a 33.5% stake in the company. In case of Panacea Biotech the stake stands at 73.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cipla and the shareholding pattern of Panacea Biotech.

Finally, a word on dividends...

In the most recent financial year, Cipla paid a dividend of Rs 8.5 per share. This amounted to a Dividend Payout ratio of 24.2%.

Panacea Biotech paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of Cipla, and the dividend history of Panacea Biotech.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.